[AIDS 2026] Africa Health Research Institute: Mobile Men study: injectable PrEP beats pills for men who travel for work
![[AIDS 2026] Africa Health Research Institute: Mobile Men study: injectable PrEP beats pills for men who travel for work](/api/imagekit?u=https%3A%2F%2Fwww.eatg.org%2Fwp-content%2Fuploads%2F2023%2F12%2F1674900.jpg&w=3840&q=75)
Results from the Mobile Men study presented at AIDS 2026 show that long-acting injectable PrEP is more effective than oral pills for men who travel frequently for work. The study highlights the feasibility of mobile clinics in providing HIV prevention services to mobile populations in Uganda and South Africa.
The first results from the Mobile Men study, presented at AIDS 2026, show that long-acting injectable cabotegravir helped men who travel for work stay on HIV prevention for longer than oral PrEP. The study also found that same-day HIV testing and starting injectable PrEP was feasible. For those taking oral PrEP, the study found that event-based PrEP (alone or combined with daily) was preferred to daily-only dosing.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in